Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.390
-0.020 (-0.59%)
Apr 17, 2026, 4:00 PM EDT - Market closed

MRVI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8714727748661,8855,509
Market Cap Growth
174.50%-38.96%-10.66%-54.04%-65.79%103.23%
Enterprise Value
1,019732.221,0251,2152,1345,713
Last Close Price
3.393.255.456.5514.3141.90
PE Ratio
--3.61-5.19-7.288.5726.86
Forward PE
----23.4242.82
PS Ratio
4.692.542.993.002.136.89
PB Ratio
2.322.222.382.083.4617.46
P/TBV Ratio
2.312.212.312.076.7034.24
P/FCF Ratio
--6.75-51.4111.783.6215.58
P/OCF Ratio
--8.20103.656.863.5214.95
EV/Sales Ratio
5.493.943.954.202.427.15
EV/EBITDA Ratio
--4.73-5.7370.913.499.71
EV/EBIT Ratio
--3.40-4.35-38.393.7210.30
EV/FCF Ratio
--10.46-68.0916.524.1016.15
Debt / Equity Ratio
0.850.850.560.700.580.96
Debt / EBITDA Ratio
-2.08-2.08-1.8332.490.860.90
Debt / FCF Ratio
-48.07-4.60-21.737.571.011.50
Net Debt / Equity Ratio
0.500.500.01-0.04-0.19-0.07
Net Debt / EBITDA Ratio
-0.68-0.68-0.03-1.07-0.17-0.04
Net Debt / FCF Ratio
-15.68-1.50-0.31-0.25-0.20-0.06
Asset Turnover
0.210.210.210.150.420.50
Inventory Turnover
3.353.352.973.153.573.31
Quick Ratio
5.405.406.347.207.077.13
Current Ratio
6.606.607.538.007.707.89
Return on Equity (ROE)
-48.59%-48.59%-37.98%-16.33%67.65%134.05%
Return on Assets (ROA)
-23.77%-23.77%-18.75%0.38%24.33%30.75%
Return on Invested Capital (ROIC)
-36.81%-36.81%-31.70%0.58%35.05%42.42%
Return on Capital Employed (ROCE)
-25.67%-25.67%-20.04%-1.77%28.73%37.42%
Earnings Yield
-15.01%-27.69%-19.27%-13.74%11.67%3.72%
FCF Yield
-8.12%-14.82%-1.95%8.49%27.59%6.42%
Buyback Yield / Dilution
-4.68%-4.68%-4.54%48.33%0.96%0.00%
Total Shareholder Return
-4.68%-4.68%-4.54%48.33%0.96%0.00%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q